Exact Sciences
EXAS
#1173
Rank
A$28.72 B
Marketcap
A$150.48
Share price
0.00%
Change (1 day)
99.44%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2025 (TTM): A-$8.54

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is A-$7.63. In 2024 the company made an earnings per share (EPS) of A-$7.99.

EPS history for Exact Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$8.546.88%
2024A-$7.99
2022A-$5.082.31%
2021A-$4.96-38.54%
2020A-$8.08692.96%
2019A-$1.02-50.69%
2018A-$2.0744%
2017A-$1.43-39.39%
2016A-$2.37-2.94%
2015A-$2.4437.1%
2014A-$1.7879.71%
2013A-$0.99-21.59%
2012A-$1.26

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
A$3.67-148.11%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
A$1.59-120.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
A$0.49-106.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
A-$6.17-19.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
A-$73.01 856.77%๐Ÿ‡บ๐Ÿ‡ธ USA